Atomoxetine, ADHD, and the ongoing debate about increased risk of suicidal behaviors: the understudied role of kappa opioid rece
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g002.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD](https://external-preview.redd.it/iVKTS19YavOujxVoQkGCwFq6hCNNzXP492aIBQUT5VU.jpg?auto=webp&s=10bcbab902c9e57f147421a226b34470bb0308c5)
Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD
![Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B978012420118700010X-f10-01-9780124201187.jpg)
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted Therapy Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01496-3/MediaObjects/41392_2023_1496_Fig1_HTML.png)
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted Therapy
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig5_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder - Document - Gale OneFile: Health and Medicine
![G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-023-01427-2/MediaObjects/41392_2023_1427_Fig2_HTML.png)
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig1_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
![IJERPH | Free Full-Text | Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up IJERPH | Free Full-Text | Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up](https://www.mdpi.com/ijerph/ijerph-18-10997/article_deploy/html/images/ijerph-18-10997-g001-550.jpg)
IJERPH | Free Full-Text | Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
![Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement](https://f6publishing.blob.core.windows.net/237309a3-53cc-412e-a55d-cb1e57ff0bf8/WJP-13-84-g001.png)
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement
![G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01427-2/MediaObjects/41392_2023_1427_Fig1_HTML.png)